Full Press Release Details
Appendix 4C Quarterly report for entities admitted on the basis of commitments
Appendix 4C - 4th Quarter
For Entities Admitted on the
Basis of Commitments
Introduced 31/3/2000. Amended 30/9/2001
Prima BioMed Ltd (ASX:PRR)
Quarter Ended ( Current Quarter )
Consolidated Statement of Cash Flows
Cash flows related to operating activities
1.1 Receipts from customers - 3
(a) staff costs (937) (3,864)
marketing (63) (268)
(c) research and development (2,752) (12,028)
(d) leased assets - -
(e) other working capital 1,035 (2,033)
Dividends received - -
1.4 Interest and other items of a similar nature received 92 1,257
1.5 Interest and other costs of finance paid - -
1.6 Income taxes benefit (22) (64)
(R&D tax refund, grants received) 101 1,691
Net operating cash flows (2,546) (15,306)
+ See chapter 19 for defined terms.
4C Quarterly report for entities admitted on the basis of commitments
1.8 Net operating cash flows (carried forward) (2,546) (15,306)
Cash flows related to investing activities
1.9 Payment for acquisition of:
(b) equity investments - -
(c) intellectual property - -
(d) physical non-current assets (288) (344)
other non-current assets - -
1.10 Proceeds from disposal of:
(a) businesses (item 5) - -
(b) equity investments - -
(d) physical non-current assets - -
(e) other non-current assets - -
1.11 Loans to other entities - -
repaid by other entities - -
1.13 Other (provide details if material) - -
Net investing cash flows (288) (344)
1.14 Total operating and investing cash flows (2,834) (15,650)
Cash flows related to financing activities
Proceeds from issues of shares, options, etc. 7,714 7,714
1.16 Transfer of shares - -
1.17 Proceeds from borrowings net finance costs - -
1.18 Repayment of borrowings - -
1.19 Dividends paid - -
1.20 Other - capital
raising costs (237) (237)
Net financing cash flows 7,477 7,477
Net increase (decrease) in cash held 4,643 (8,173)
1.21 Cash at beginning of quarter/year to date 25,179 38,037
1.22 Exchange rate adjustments to item 1.21 200 (158)
1.23 Cash at end of quarter 30,022 30,022
+ See chapter 19 for defined terms.
4C Quarterly report for entities admitted on the basis of commitments
Payments to Directors of the Entity and
Associates of the Directors
Payments to Related Entities of the Entity and Associates of the Related Entities
1.24 Aggregate amount of payments to
the parties included in item 1.2 198
1.25 Aggregate amount of loans to the parties included in item 1.11 -
1.26 Explanation necessary for an understanding of the transactions
Directors fees and consulting fees at normal commercial rates
Non-Cash Financing and Investing Activities
2.1 Details of financing and investing transactions which have had a material effect on consolidated Assets and liabilities but did not involve cash flows
2.2 Details of outlays made by other entities to establish or increase their share in businesses in which the reporting
entity has an interest
Financing Facilities Available
Add notes as necessary for an understanding of the position. (See AASB 1026 paragraph 12.2).
Amount Available Amount Used
3.1 Loan facilities - -
3.2 Credit standby arrangements - -
+ See chapter 19 for defined terms.
4C Quarterly report for entities admitted on the basis of commitments
Reconciliation of Cash
Reconciliation of cash at the end of the quarter Current Quarter Previous
(as shown in the consolidated statement of cash flows) Quarter
to the related items in the accounts is as follows. $A 000 $A 000
4.1 Cash on hand and at bank 13,793 10,546
4.2 Deposits at call 8,229 4,633
4.4 Other (Term Deposit) 8,000 10,000
Total: Cash at end of quarter (item 1.23) 30,022 25,179
Acquisitions and Disposals of Business Entities
Acquisitions Disposals
5.1 Name of entity - -
5.2 Place of incorporation or registration - -
5.3 Consideration for acquisition or disposal - -
5.4 Total net assets - -
5.5 Nature of business -
Compliance Statement
1 This statement has been prepared under accounting policies which comply with accounting standards as defined in the Corporations Act (except to the extent that information is not
required because of note 2) or other standards acceptable to ASX.
2 This statement does give a true and fair
view of the matters disclosed.
Sign Here: Date: Friday 26th July 2013
Print Name: Deanne Miller
+ See chapter 19 for
4C Quarterly report for entities admitted on the basis of commitments
1. The quarterly report provides a basis for informing the market how the entity s activities have been financed for
the past quarter and the effect on its cash position. An entity wanting to disclose additional information is encouraged to do so, in a note or notes attached to this report.